ArticleBritish journal of cancer2023

Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, and clinical activity of OBI-3424 in patients with advanced or metastatic solid tumors.

Apostolia Maria Tsimberidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.